hypoglycaemia

Needle-free treatment for hypoglycaemia gets FDA approval

By Staff Writer

Aptar Group’s Unidose Powder System has been approved by the FDA for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people with diabetes. This marks the first FDA approval of a prescription drug using Aptar’s patented Unidose Powder System and is Aptar’s first combination of a drug delivery device with a...